Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123
Status:
Completed
Trial end date:
2019-09-20
Target enrollment:
Participant gender:
Summary
The purpose of the study is to find out if the small dose of radioiodine, that is used for
the dosimetry study on patients with differentiated thyroid cancer, may stun the cancer cells
and make the thyroid cancer treatment less effective.